- Sodium monofluoroacetate
- Fluoroacetic acid, sodium salt
Fine, white, odorless powder, hygroscopic.
Field rodenticide, vertibrate pesticide.
Registry Numbers and Inventories.
EC Index Number
Very toxic; Dangerous for the Environment
R 26/27/28 50
S 13 22 36/37 45 61
Agricultural Chemical and Pesticide; Mutagen; Reproductive Effector; Human Data
Swiss Giftliste 1
Melting point, °C
> 1 g/cm3
Solubility in water
Hazards and Protection.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Wear appropriate eye protection and protective clothing to prevent skin and eye contact. Facilities for quickly drenching the body should be provided within the immediate work area for emergency use where there is a possibility of exposure.
Maximum concentration for use: 2.5 mg/m<sup>3</sup>; Respirator class(es): any air-purifying, full-facepiece respirator with a high-efficiency particulate filter. Any supplied-air respirator that has a tight-fitting facepiece and is operated in a continuous-flow mode. Any powered, air-purifying respirator with a tight-fitting facepiece and a high-efficiency particulate filter.
Keep sparks, flames, and other sources of ignition away. Keep material out of water sources and sewers.
Reacts as bases to neutralize acids.
Decomposition at 200 C.
Stay upwind; keep out of low areas. Wear self-contained, positive pressure breathing apparatus and full protective clothing.Use dry chemical, carbon dioxide, water spray, or foam. For large fires, use water spray, fog, or foam.
May burn but does not readily ignite. Not combustible.
When heated to decomposition, it emits highly toxic fumes of sodium oxide and fluorides. Avoid decomposing heat.
Fire may produce irritating, corrosive and/or toxic gases.
TLV (as TWA): ppm; 0.05 mg/m3 (skin) (ACGIH 1995-1996). OSHA PEL: TWA 0.05 mg/m3 skin NIOSH REL: TWA 0.05 mg/m3 ST 0.15 mg/m3 skin NIOSH IDLH: 2.5 mg/m3
Abnormally low blood pressure, rapid heart rate and irregular pulse may be noted. Neurologic effects may include hyperactive behavior, auditory hallucinations, cerebellar dysfunction, loss of speech, paresthesias, seizures, coma, carpopedal spasm and neurologic impairment. No data were available to assess the teratogenic potential of this agent. <br>No data were available to assess the potential effects of exposure to this agent during pregnancy or lactation. <br>Observed paternal toxic effects in male rats include changes in the testes, epididymis, and sperm duct.
Nausea, vomiting, excessive salivation and diarrhea may be noted.
Respiratory depression and pulmonary edema have been reported.
Avoid any skin contact. See Inhalation.
Numbness of the face and facial twitching, blurred vision and nystagmus may occur.
Do not induce emesis. Activated charcoal: administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists. There is no known effective specific treatment for fluoroacetate exposure, but symptomatic supportive therapy should be provided.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility. There is no known effective specific treatment for fluoroacetate exposure, but symptomatic supportive therapy should be provided.
USCG CHRIS Code
2915 90 80
Std. Transport #